IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$16.7M
2
+$13.6M
3
+$9.11M
4
SAGE
Sage Therapeutics
SAGE
+$6.18M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.32M

Top Sells

1
+$12.7M
2
+$11.7M
3
+$11.3M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.2M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-86,865
102
– –
-410
103
– –
-86,035
104
– –
-61,500
105
– –
-125,000
106
– –
-61,433
107
– –
-14,770
108
– –
0
109
– –
0
110
– –
-100,000
111
– –
0
112
– –
-51,606
113
– –
-329
114
– –
-7,064
115
– –
-615,856
116
– –
-53,703
117
– –
-38,600
118
– –
-5,953
119
– –
-26,831
120
– –
-225,991
121
– –
0
122
– –
0
123
– –
0
124
– –
-105,341
125
– –
-70,277
2 3 4
5
6